Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Clinical Trial ID NCT01189643

PubWeight™ 2.39‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01189643

Top papers

Rank Title Journal Year PubWeight™‹?›
Next 100